These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 28849081)

  • 1. Lercanidipine attenuates angiotensin II-induced cardiomyocyte hypertrophy by blocking calcineurin-NFAT3 and CaMKII-HDAC4 signaling.
    Chen Y; Yuan J; Jiang G; Zhu J; Zou Y; Lv Q
    Mol Med Rep; 2017 Oct; 16(4):4545-4552. PubMed ID: 28849081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin Attenuates Angiotensin II-induced Cardiomyocyte Hypertrophy by Inhibiting the Ca(2+)/Calcineurin-NFAT Signaling Pathway.
    Yin Z; Wang X; Zhang L; Zhou H; Wei L; Dong X
    Cardiovasc Ther; 2016 Feb; 34(1):21-9. PubMed ID: 26506219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-type Ca2+ channel blockers prevent cardiac cell hypertrophy through an inhibition of calcineurin-NFAT3 activation as well as L-type Ca2+ channel blockers.
    Horiba M; Muto T; Ueda N; Opthof T; Miwa K; Hojo M; Lee JK; Kamiya K; Kodama I; Yasui K
    Life Sci; 2008 Mar; 82(11-12):554-60. PubMed ID: 18275974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astragalus polysaccharide inhibits isoprenaline-induced cardiac hypertrophy via suppressing Ca²⁺-mediated calcineurin/NFATc3 and CaMKII signaling cascades.
    Dai H; Jia G; Liu X; Liu Z; Wang H
    Environ Toxicol Pharmacol; 2014 Jul; 38(1):263-71. PubMed ID: 24975447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of PEP-19 suppresses angiotensin II-induced cardiomyocyte hypertrophy.
    Xie YY; Sun MM; Lou XF; Zhang C; Han F; Zhang BY; Wang P; Lu YM
    J Pharmacol Sci; 2014; 125(3):274-82. PubMed ID: 25048017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Over-expression of BDNF inhibits angiotensin II-induced apoptosis of cardiomyocytes in SD rats].
    Cao J; Wu Y; Liu G; Li Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Mar; 34(3):218-224. PubMed ID: 29773102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides.
    Tokudome T; Horio T; Kishimoto I; Soeki T; Mori K; Kawano Y; Kohno M; Garbers DL; Nakao K; Kangawa K
    Circulation; 2005 Jun; 111(23):3095-104. PubMed ID: 15939815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure.
    Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S
    Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calmodulin kinases II and IV and calcineurin are involved in leukemia inhibitory factor-induced cardiac hypertrophy in rats.
    Kato T; Sano M; Miyoshi S; Sato T; Hakuno D; Ishida H; Kinoshita-Nakazawa H; Fukuda K; Ogawa S
    Circ Res; 2000 Nov; 87(10):937-45. PubMed ID: 11073891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evodiamine Inhibits Angiotensin II-Induced Rat Cardiomyocyte Hypertrophy.
    He N; Gong QH; Zhang F; Zhang JY; Lin SX; Hou HH; Wu Q; Sun AS
    Chin J Integr Med; 2018 May; 24(5):359-365. PubMed ID: 28875323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of hydrogen sulfide (H
    Wu Y; Guo YY; Zhang YY; Zhang Y
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Jan; 34(1):29-34. PubMed ID: 29926655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COX-2 is involved in ET-1-induced hypertrophy of neonatal rat cardiomyocytes: role of NFATc3.
    Li H; Gao S; Ye J; Feng X; Cai Y; Liu Z; Lu J; Li Q; Huang X; Chen S; Liu P
    Mol Cell Endocrinol; 2014 Feb; 382(2):998-1006. PubMed ID: 24291639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of distinct sources of Ca(2+) on cardiac hypertrophy in cardiomyocytes.
    Xu H; Zhang Y; Sun J; Wei J; Sun L; Zhang J
    Exp Biol Med (Maywood); 2012 Mar; 237(3):271-8. PubMed ID: 22345300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telmisartan suppresses cardiac hypertrophy by inhibiting cardiomyocyte apoptosis via the NFAT/ANP/BNP signaling pathway.
    Li X; Lan Y; Wang Y; Nie M; Lu Y; Zhao E
    Mol Med Rep; 2017 May; 15(5):2574-2582. PubMed ID: 28447738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytosolic CARP promotes angiotensin II- or pressure overload-induced cardiomyocyte hypertrophy through calcineurin accumulation.
    Chen C; Shen L; Cao S; Li X; Xuan W; Zhang J; Huang X; Bin J; Xu D; Li G; Kitakaze M; Liao Y
    PLoS One; 2014; 9(8):e104040. PubMed ID: 25089522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD38 promotes angiotensin II-induced cardiac hypertrophy.
    Guan XH; Hong X; Zhao N; Liu XH; Xiao YF; Chen TT; Deng LB; Wang XL; Wang JB; Ji GJ; Fu M; Deng KY; Xin HB
    J Cell Mol Med; 2017 Aug; 21(8):1492-1502. PubMed ID: 28296029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipopolysaccharide induces cellular hypertrophy through calcineurin/NFAT-3 signaling pathway in H9c2 myocardiac cells.
    Liu CJ; Cheng YC; Lee KW; Hsu HH; Chu CH; Tsai FJ; Tsai CH; Chu CY; Liu JY; Kuo WW; Huang CY
    Mol Cell Biochem; 2008 Jun; 313(1-2):167-78. PubMed ID: 18398669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CaMKII negatively regulates calcineurin-NFAT signaling in cardiac myocytes.
    MacDonnell SM; Weisser-Thomas J; Kubo H; Hanscome M; Liu Q; Jaleel N; Berretta R; Chen X; Brown JH; Sabri AK; Molkentin JD; Houser SR
    Circ Res; 2009 Aug; 105(4):316-25. PubMed ID: 19608982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DY-9760e inhibits endothelin-1-induced cardiomyocyte hypertrophy through inhibition of CaMKII and ERK activities.
    Lu YM; Shioda N; Han F; Kamata A; Shirasaki Y; Qin ZH; Fukunaga K
    Cardiovasc Ther; 2009; 27(1):17-27. PubMed ID: 19207476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3,3'-Diindolylmethane attenuates cardiac H9c2 cell hypertrophy through 5'-adenosine monophosphate-activated protein kinase-α.
    Zong J; Wu QQ; Zhou H; Zhang JY; Yuan Y; Bian ZY; Deng W; Dai J; Li FF; Xu M; Fang Y; Tang QZ
    Mol Med Rep; 2015 Jul; 12(1):1247-52. PubMed ID: 25816057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.